Prostate Cancer Research Inc
- Assets
- $30.6k
- Revenue
- $22.7k
- Investments
- $0.0
- Employees
- 3
- Location
- Dover, DE
- Founding
- Data as of
- 12/2023
- EIN
- 85-3336070
Organization Overview
Prostate Cancer Research Inc is located in Dover, DE. According to its NTEE Classification (H40) the organization is classified as: Diseases of Specific Organs Research, under the broad grouping of Medical Research and related organizations. As of 12/2023, Prostate Cancer Research Inc employed 3 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Prostate Cancer Research Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Prostate Cancer Research Inc generated $22.7k in total revenue. This represents a relatively dramatic decline in revenue. Over the past 3 years, the organization has seen revenues fall by an average of (11.8%) each year. All expenses for the organization totaled $420.7k during the year ending 12/2023. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
PROSTATE CANCER RESEARCH, INC. (THE ORGANIZATION) IS A NON-PROFIT ORGANIZATION FORMED SEPTEMBER 28, 2020 TO HELP DEVELOP AND DELIVER BREAKTHROUGH MEDICINES AND TREATMENTS FOR A WORLD WHERE PEOPLE ARE FREE FROM THE IMPACT OF PROSTATE CANCER. PROSTATE CANCER RESEARCH, INC'S GOAL IS TO INVEST IN THE SCIENCE, RESEARCH AND MEDICAL BREAKTHROUGHS FOR THE FUTURE.
Describe the Organization's Program Activity:
Part 3 - Line 4a
PRC WORKS TO PROVIDE RESEARCH ON PROSTATE CANCER FOCUSING ON TWO CORE THEMES. 1 - HOW TO IMPROVE THE CLASSIFICATIONS OF ADVANCED PROSTATE CANCER, AND THEIR ABILITY TO PREDICT WHICH TREATMENTS WILL WORK BEST FOR INDIVIDUAL PATIENTS BASED ON THEIR PARTICULAR PROSTATE CANCER SUBTYPE. 2 DISCOVERING NEW TREATMENTS FOR ADVANCED PROSTATE CANCER BY INVESTIGATING HOW TO CONTAIN CANCEROUS CELLS WITHIN THE PROSTATE AND PREVENT IT FROM BECOMING ADVANCED, AND FINDING THERAPIES FOR WHEN THE DISEASE HAS BECOME ADVANCED.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
PDF Copies of 990 Filings
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Michelle Mcguinness Director | Trustee | 1 | $0 |
Adam Schayowitz Director | Trustee | 1 | $0 |
Christopher Shepard Director | Trustee | 1 | $0 |
Suman Shirodkar Director | Trustee | 1 | $0 |
Christina Renner-Thomas Director | Trustee | 1 | $0 |
Catherine C Turkel Director | Trustee | 1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $22,687 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $22,687 |
| Total Program Service Revenue | $0 |
| Investment income | $0 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $22,687 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $220,399 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $114,378 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $12,019 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $22,955 |
| Fees for services: Accounting | $0 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $0 |
| Advertising and promotion | $33,945 |
| Office expenses | $0 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $1,089 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $484 |
| All other expenses | $0 |
| Total functional expenses | $420,739 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $30,551 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $30,551 |
| Accounts payable and accrued expenses | $0 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $753,173 |
| Total liabilities | $753,173 |
| Net assets without donor restrictions | -$722,622 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $30,551 |
Grants Awarded
Over the last fiscal year, Prostate Cancer Research Inc has awarded $220,399 in support to 4 organizations.
| Grant Recipient | Amount |
|---|---|
CONVENE PURPOSE: GENERAL SUPPORT | $24,271 |
BAYLOR COLLEGE OF MEDICINE PURPOSE: GENERAL SUPPORT | $35,826 |
CLARK ATLANTA UNIVERSITY PURPOSE: GENERAL SUPPORT | $63,182 |
DANA-FARBER CANCER INSTITUTE PURPOSE: GENERAL SUPPORT | $97,120 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Baruch S Blumberg Institute Doylestown, PA | $7,307,209 | $8,126,046 |
National Pancreas Foundation Bethesda, MD | $1,911,190 | $2,721,582 |
Systemic Lupus International Collaborating Clinics Pittsburgh, PA | $568,083 | $518,790 |
Prostate Cancer Research Inc Dover, DE | $30,551 | $22,687 |
Defy Foundation West Chester, PA | $146,745 | $0 |
World Free Of Als Inc Millville, PA | $0 | $67 |